Key facts
- This page summarizes Geoffrey S. Dow's Form 4 filing for 60 DEGREES PHARMACEUTICALS, INC. (SXTP).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 15 Jun 2026, 16:50.
Geoffrey S. Dow - 12 Jun 2026 Form 4 Insider Report for 60 DEGREES PHARMACEUTICALS, INC. (SXTP)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- SXTP
- Reported as of
- 12 Jun 2026
- Net transaction value
- +$10,131
- SEC form
- 4
- Accepted by SEC
- 15 Jun 2026, 16:50:47 UTC
- Prior SEC filing
- 16 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Geoffrey Dow
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Geoffrey S. Dow filed Form 4 for 60 DEGREES PHARMACEUTICALS, INC. (SXTP) on 15 Jun 2026.
Change
- Previous filing in this sequence was filed on 16 Dec 2025.
- Current net transaction value: +$10,131.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001977231
Primary reporting owner
DOW GEOFFREY S
- Relationship
- President and CEO, Director
- Address
- C/O 60 DEGREES PHARMACEUTICALS, INC., 1025 CONNECTICUT AVENUE NW SUITE 1000, WASHINGTON
- Signature
- /s/ Geoffrey Dow
- Signature date
- 15 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SXTP
transaction
Common Stock
Purchase
- Transaction value
- $10,131
- Shares
- +7,350
- Change %
- +44%
- Price
- $1.38
- Shares after
- 24,131
- Date
- 12 Jun 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.